Whereupon We Pontificate About Poor Media Outlet Choices

3 Likes

If Books Could Kill opened their premium “pundit portraits” series with an episode about her and Chris Cillizza, and these takes were highlights.

1 Like

Has she written any other recent articles telling us to calm down? :harold:

Shut it down, we are done here

the times has literally become a new yorker cartoon

6 Likes

just another thing trump is inadvertently right about

This year is going to be so miserable

1 Like

You have a MAGA dad?

1 Like

Shame on Harvard. Fuck off letting the bullies win.

Lolololol wonder why they are “offering” this discount

https://x.com/megtirrell/status/1741857930587123881?s=46&t=XGja5BtSraUljl_WWUrIUg

Cool now do the rest of the healthcare system.

what’s the context here? whatever it is, this seems like an easy win for Biden to clobber trump with. “trump kept saying his healthcare plan is two weeks away, but I did this actual thing and magically made big pharma roll over”

The inflation reduction act capped insulin prices and this HEALTH CARE REPORTER FOR CNN presents it as an act of benevolence from big pharma

yeah but taht cap is just for medicare, isn’t it? This sounds like they’re doing it across the board.

So weird, the word “Biden” was nowhere in that report. It’s almost like they don’t want him to get any credit for doing anything good because they want Donald Trump to win the next election because they get better ratings when Donald Trump is the president.

Worth noting the background that got her to be the healthcare reporter. 6.5 years at Bloomberg as Small Caps/Media/Consumer Reporter → Health/Science/Pharma Reporter → BioTech Reporter. 10 years at CNBC at Biotech/Pharma Reporter and then Senior Health and Science Reporter for three years.

So most of her career has been spent reporting on Health/Science/Pharma/Biotech stocks.

1 Like

How does cutting the price by 70% save them hundreds of millions per year?

Something to do with forcing them to pay Medicaid the difference between their average market price and their list price if they want their drugs covered under Medicaid. There’s also an inflationary component if they’ve increased the price of the drug faster than inflation.

Previously this was capped at 100% of the average market price, but that cap was removed in the Inflation Reduction Act.

I don’t know the exact details and mechanisms, but it looks to me like Biden and Dems found a way to make them stop price gouging insulin by making the Medicaid rebate payments punitively high on grossly overpriced drugs.

This kicked in on 1/1/24 so obviously the changes being made on the first weren’t out of the goodness of Eli Lilly, Sanofi, etc’s hearts.

1 Like

It’s basically due to a weird rebate formula. But this whole rebate thing has nothing to do with the Inflation Reduction Act, it was actually a result of legislation passed a year eariler. The rebate formula itself comes from even farther in the past. Details here:

1 Like